Filing Details
- Accession Number:
- 0001214659-22-002681
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-02-14 16:51:29
- Reporting Period:
- 2022-02-11
- Accepted Time:
- 2022-02-14 16:51:29
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1576263 | Mirati Therapeutics Inc. | MRTX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1197355 | J Henry Fuchs | C/O Mirati Therapeutics Inc. 3545 Cray Court San Diego CA 92121 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-02-11 | 6,000 | $20.54 | 12,021 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2022-02-11 | 5,000 | $20.54 | 17,021 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-02-11 | 2,090 | $104.76 | 14,931 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-02-11 | 8,700 | $105.80 | 6,231 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-02-11 | 210 | $106.34 | 6,021 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non Qualified Stock Option (right to buy) | Disposition | 2022-02-11 | 6,000 | $0.00 | 6,000 | $20.54 |
| Common Stock | Non Qualified Stock Option (right to buy) | Disposition | 2022-02-11 | 5,000 | $0.00 | 5,000 | $20.54 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2017-09-09 | 2024-09-08 | No | 4 | M | Direct |
| 0 | 2014-09-09 | 2024-09-08 | No | 4 | M | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2021.
- This transaction was executed in multiple trades at prices ranging from $104.23 to $105.20. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $105.28 to $106.20. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $106.33 to $106.555. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
